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Reconsidering the roles of endogenous estrogens and xenoestrogens: 
the membrane estradiol receptor G protein-coupled receptor 30 
(GPR30) mediates the effects of various estrogens
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Abstract.  Estrone (E1) and estriol (E3) are considered “weak” estrogens, which exert suppressive effects through 
estrogen receptors α and β. However, recent studies have demonstrated that E1 and E3, as well as estradiol (E2), 
suppress gonadotropin-releasing hormone-induced luteinizing hormone secretion from bovine gonadotrophs via 
G-protein-coupled receptor 30, which is expressed in various reproductive organs. Currently, there is a lack of 
fundamental knowledge regarding E1 and E3, including their blood levels. In addition, xenoestrogens may remain 
in the body over long time periods because of enterohepatic circulation. Therefore, it is time to reconsider the roles 
of endogenous estrogens and xenoestrogens for reproduction.
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Estrogen receptors
Estradiol (E2), which is secreted from the 
ovaries, is a powerful feedback regulator, 
controlling the secretion of gonadotropin-
releasing hormone (GnRH) from the hypo-
thalamus and the secretion of luteinizing 
hormone (LH) form the anterior pituitary. 
Blood E2 concentrations fluctuate in heifers 
and cows between 0.004 nM (1 pg/ml) and 
0.030 nM (8 pg/ml) during the luteal phase of 
the estrous cycle [1, 2]. Small concentrations 
exert a negative feedback effect on GnRH 
secretion from the hypothalamus [3–5], and 
suppress the amounts of LH mRNA in the 
anterior pituitary [6].
E2 binds to nuclear-localized estrogen 
receptors α or β (ERα or ERβ), and changes 
the mRNA expression of the genes that 
produce GnRH and LH in the hypothalamus 
or the pituitary, respectively [7–9]. However, 
E2 also suppresses LH production in a rapid, 
nongenomic manner within the pituitary via 
binding to the G protein-coupled receptor 
30 (GPR30; or G protein-coupled estrogen 
receptor 1) [10–14]. GPR30 can bind to E2 to 
initiate several rapid, nongenomic signaling 
events in the cytoplasm [15].
Significant effects of estrone 
and estriol
Estrone (E1) and estriol (E3) have been 
explained as “weak” estrogens compared to 
E2, with respect to genomic actions [16]. 
However, according to a recent study, both 
E1 and E3 have been shown to be strong 
estrogens in the nongenomic signaling 
pathways, and elicit functional responses in 
rat lactotroph-like cells [16]. Additionally, 
E1 exerts a direct, nongenomic action on 
rat aortic metabolism [17]. However, there 
are no reports on the nongenomic effects of 
E1 and E3 on LH secretion by gonadotrophs 
in animals, including women and rodents.
Therefore, we evaluated whether GPR30 
mediated E1 and E3 to suppress GnRH-
induced LH secretion from bovine pituitary 
[18]. As shown in Fig. 1, pre-treatment with 
picomolar levels, but not femtomolar or 
nanomolar levels, of E2, E1, or E3 suppressed 
the GnRH-induced LH secretion. The GPR30 
antagonist (G36), but not ERα antagonist 
(MPP), abrogate such suppressing effects 
of picomolar levels of E2, E1, and E3 on 
LH secretion [20]. Therefore, E1 and E3, 
as well as E2, suppress GnRH-induced LH 
secretion from anterior pituitary cells in a 
nongenomic manner, via GPR30 binding (Fig. 
2). Previous studies reported that in ruminants, 
the intramuscular injection of E3 induces an 
LH surge earlier than an E2 injection [19, 20]. 
The nongenomic effect of E1 on LH secretion 
may have an important role in controlling the 
number of ovulations in heifers treated for 
superovulation [21]. Therefore, we need to 
reconsider the functions of E1 and E3, and 
further studies are required to evaluate the 
functional significance of the findings, given 
that E2, E1, and E3 exert similar, nongenomic 
suppressive effects via GPR30 binding in 
gonadotrophs.
As shown in Fig. 1, both E1 and E3 can 
markedly affect the GnRH-induced LH secre-
tion rapidly. Iqbal et al. [11] had suggested 
that E2 might have a biphasic effect on LH 
secretion by ovine gonadotropes in vivo, with 
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a rapid suppression of LH release (negative 
feedback) initially, followed by a positive 
feedback event many hours later. Iqbal et al. 
[11] had also reported that E2 might activate 
the MAPK pathway for exerting its time-
delayed positive feedback effect. Therefore, 
the nanomolar concentration of E1, E2, and E3 
may have activated the MAPK pathway earlier 
than the picomolar concentrations, suggesting 
that both ligand dosage and duration of action 
are important for their suppressive effects on 
LH secretion by gonadotrophs.
Cytoplasmic pathway of GPR30
Unlike the cytoplasmic pathways for ERα 
and ERβ, which control gene expression 
in various cells, little is known about the 
cytoplasmic signaling pathway of activated 
GPR30. Few studies have recently revealed 
that protein kinase A (PKA) and phosphory-
lated extracellular signal-regulated kinase 
(pERK) are involved in the cytoplasmic 
signaling pathways of GPR30 in mouse 
trigeminal ganglia [22] and rat liver [23]. 
Within 15 min of E2 treatment, LH secretion 
from ovine AP decreases, and pERK levels 
increase [11, 24]. A GPR30 antagonist, G36, 
inhibits ERK phosphorylation by estrogen 
in SKBr3 cells [25]. Furthermore, we have 
previously reported that PKA and pERK 
are the intracellular mediators downstream 
of GPR30, which induce the nongenomic 
suppression of GnRH-induced LH secretion 
from bovine AP cells by E2 or GPR30-specific 
agonists [26].
Crosstalk between ERs and 
GPR30 in gonadotrophs
Whether GPR30 acts as an autonomous 
ER in vivo or interacts with nuclear estrogen 
receptor signaling pathways in response to 
estrogens is controversial. As reviewed by 
Romano and Gorelick [27], several lines of 
evidence support the role of GPR30 as an au-
tonomous estrogen receptor in vivo. However, 
evidence supporting the interaction of GPR30 
with ER signaling is also available. These 
reports suggest that GPER may either activate 
ER or form a complex with ER. Romano and 
Gorelick [27] concluded that the degree to 
which GPR30 influences nuclear estrogen 
receptor signaling likely depends on the cell 
type, developmental stage, and pathology. In 
our study, GPR30 antagonists, but not ERα 
antagonists, abrogated the suppressive effect 
of picomolar concentrations of E2, E1, and E3 
on LH secretion from bovine gonadotrophs 
[18]. Our data suggested that GPR30 is an 
autonomous estrogen receptor that suppressed 
the GnRH-induced LH secretion from bo-
vine gonadotrophs. However, any crosstalk 
between ER and GPR30 may have important 
roles in the nongenomic effects of E1, E2, 
and E3, which induce prolactin secretion 
from GH3/B6/F10 rat pituitary tumor cells 
[16]. Therefore, further studies are required 
to clarify the mechanism underlying the 
nongenomic effects of endogenous estrogens 
in ruminants and other species.
Lack of fundamental knowledge 
regarding E1 and E3
Little is known about blood E1 concen-
Fig. 1. The effects of pretreatment with femtomolar, picomolar, or nanomolar levels of E2, E1, or E3 
on GnRH-induced LH secretion from cultured bovine anterior pituitary cells (from Otsuka 
and Kadokawa [18]). + indicates P < 0.05, and ++ indicates P < 0.01 compared to the control 
(white bar); * indicates P < 0.05, and ** indicates P < 0.01 compared to GnRH alone (dark 
grey bar).
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trations in domestic animals. The blood E1 
concentration in cows is probably in the 
picomolar range during the estrous cycle, 
and increases to nanomolar levels during 
pregnancy [28]. However, we found no reports 
about blood E3 concentration in cows. In 
animals, E3 is synthesized from E1 and E2 
[29, 30]. Thus, it is reasonable to assume 
that blood E3 concentrations in cows might 
follow the same trend as blood E1 concentra-
tions. Although further studies are required 
to clarify the blood concentrations of E1 
and E3 in domestic animals, the picomolar 
concentrations of E1 and E3, as well as E2, 
may exert similar negative feedback effects 
from the ovaries to gonadotrophs to control 
GnRH-induced LH suppression during the 
estrous cycle.
Xenoestrogens
We must be cautious that the GPR30 
expressed on cells in various reproductive 
organs may bind xenoestrogens as well 
as endogenous estrogens. Xenoestrogens 
include plant estrogens, mycoestrogens, and 
environmental estrogens.
Plants have chemical mechanisms to 
defend against attacks by animals, includ-
ing insects and vertebrate herbivores. 
Phytochemical options exist by which plants 
can modulate the fertility of herbivores [31]. 
Phytoestrogens are most well-known group of 
phytochemical mimics of vertebrate reproduc-
tive hormones [32]. However, little is known 
about whether phytoestrogens are GPR30 
ligands. A previous study demonstrated that 
the phytoestrogen genistein is a GPR30 ligand 
in human periodontal ligament cells [33]. 
Although phytoestrogens have been studied 
in menopausal women, many of their effects 
remain unstudied in both human and domestic 
animals, as reviewed by other authors [34, 35].
α-Zearalanol (or Zeranol; α-ZAL) is a 
non-steroidal estrogenic compound, derived 
from zearalenone (ZEN), the mycoestrogen 
produced by Fusarium [36]. It has been 
established that α-ZAL implantation delays 
puberty, increases the incidence of non-
ovulatory estrus, and retards reproductive tract 
development in heifers [37]. Previous studies 
also indicate that in ruminants, α-ZAL sup-
presses LH secretion in a rapid, nongenomic 
manner in vivo [38–41].
We previously reported that ZEN and five 
known ZEN metabolites rapidly suppressed 
GnRH-induced LH secretion, by decreasing 
cytoplasmic cyclic adenosine monophosphate 
without decreasing expression of the LHα 
and LHβ subunits [14, 42]. It is important to 
note that α-ZAL has been detected in cereal 
grains and animal feeds [43], cattle urine, and 
ruminant bodies worldwide [44].
In our study, we estimated that ZEN had the 
greatest nongenomic inhibiting effect on LH 
secretion in terms of magnitude and effective 
concentration range, followed by α-ZAL, 
zearalanone (ZAN), α-zearalenol (α-ZOL), 
β-zearalenol (β-ZOL), and β-zearalanol 
(β-ZAL) [42]. It is important to note that the 
relative strengths of the nongenomic inhibiting 
effects caused by each ZEN analog differ from 
the reported relative strengths of their genomic 
effects measured by the MCF7 human breast 
cell proliferation assay [45], as summarized 
in Fig. 3.
Biehl et al. reported that ZEN administered 
orally was rapidly and efficiently absorbed 
and metabolized by pigs, reaching maximum 
plasma concentrations within 2 or 3 h [46]. 
These authors also reported that 45% of the 
administered ZEN was excreted in bile, of 
which 85% was reabsorbed into the systemic 
circulation [45]. It is unknown whether ZEN 
analogs are subject to this type of “enterohe-
patic circulation” in ruminants. However, E2 
undergoes enterohepatic circulation [47]; the 
bile of ruminants contains ZEN, α-ZOL, and 
β-ZOL [48]. The half-life for the elimination 
of ZEN from the blood of ruminants is quite 
long (28.6 h) [49]. Therefore, ZEN remains in 
ruminant bodies fed with ZEN-contaminated 
feed for long periods; it is possible that ZEN 
concentrations attain values at which LH 
secretion is inhibited in vivo.
Thomas and Dong [50] reported that 
bisphenol A (BPA) and nonylphenol, both 
well-known environmental estrogens and 
endocrine disruptors, imperfectly mimic the 
effects of physiologic estrogens via binding 
to ERα, ERβ, and GPR30. These authors also 
reported that the binding affinity of BPA and 
ZEN to GPR30 is less than 3% relative to 
that of E2, and that BPA shows a higher 
affinity to GPR30 than to ERα and ERβ. If 
both ligand dosage and duration of action are 
important for the suppressive effect on LH 
secretion by gonadotrophs, the low affinity 
of xenoestrogens to GPR30 may modulate 
the duration of action to allow the biphasic 
effect on LH secretion by gonadotrophs. Thus, 
there is a need to test the hypothesis that the 
rapid negative feedback from low-affinity 
xenoestrogens may appear before the effects 
of E2, while the positive feedback may appear 
after the effects of E2.
Bisphenol S (BPS) is an alternative to BPA 
in plastic consumer products and thermal pa-
per. However, Viñas and Watson [51] reported 
that BPS, once considered a safe substitute for 
BPA, disrupts membrane-initiated E2-induced 
cell signaling, leading to altered proliferation, 
cell death, and prolactin release in a rat cell 
line. Substituting BPA with BPS in consumer 
products is a fast process, especially in the 
U.S. [52]; BPS is now ubiquitous in the envi-
Fig. 2. Genomic and nongenomic pathways controlling LH secretion from bovine gonadotrophs.
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ronment (including water, sediment, sludge, 
indoor dust and air, consumer products, food, 
and human urine) worldwide [52]. Recent 
studies have demonstrated that BPS may have 
adverse effects on the reproductive, endocrine, 
and nervous systems of animals and humans, 
and may trigger oxidative stress [52]. Further 
studies are required to clarify the effects of 
environmental estrogens mediated by GPR30 
in domestic animals.
GPR30 is expressed in various 
reproductive organs
Recently, GPR30 expression has been 
shown to be important in various reproductive 
functions such as testosterone production 
in human testes [53], lordosis behavior in 
rats [54], SBD-1 gene expression in ovine 
oviduct epithelial cells [55], mouse oocyte 
maturation [56], and mediation of the direct 
effects of E2 in immortalized GnRH neurons 
[57]. The GPR30 gene is expressed in the 
granulosa and theca cells, although its role 
in the ovary is not yet clear [58]. GPR30 rap-
idly stimulates GnRH secretion from GnRH 
neurons [59]. Therefore, further studies are 
required to evaluate the hypothesis that vari-
ous endogenous estrogens and xenoestrogens 
are risk factors for reproductive suppression 
in domestic animals.
Species difference in GPR30
As mentioned previously, further studies 
are required to clarify the physiological 
significance of E1 and E2 in other animals. 
Matthews et al. [60] reported that ERs from 
different species exhibit differential ligand 
preferences and relative binding affinities for 
estrogenic compounds due to the differences 
in their amino acid sequences. The GPR30 
gene is conserved in Homo (H.) sapiens, 
Macaca (M.) mulatta, Bos (B.) taurus, Canis 
(C.) lupus, Mus (M.) musculus, Rattus (R.) 
norvegicus, Gallus (G.) gallus, Xenopus (X.) 
tropicalis, and Danio (D.) rerio (https://www.
ncbi.nlm.nih.gov/homologene/15855). The 
amino acid sequence of B. taurus GPR30 
(XP_002698215.1) has 7 transmembrane 
helices, similar to the GPR30 of other ani-
mals (determined by the SOSUI algorithm; 
http://harrier.nagahama-i-bio.ac.jp/sosui/). 
However, the pairwise alignment scores of 
GPR30 of H. sapiens with that of B. taurus is 
lower (84.6% of identity) than that with those 
of other mammals [M. mulatta (98.1%), C. 
lupus (89.7%), M. musculus (86.9%), and R. 
norvegicus (86.1%)]. This could be because 
the amino acid sequences of the extracellular 
N-terminus region of GPR30 of different 
species differ substantially from each other. 
Therefore, it can be assumed that GPR30 plays 
a wide variety of roles in different organs of 
carnivores, omnivores, and herbivores that 
consume large quantities of phytoestrogens.
Conclusion
Endogenous estrogens and xenoestrogens 
may play important roles in the reproduction 
process via binding to GPR30 in various cells; 
however, little is known about the mechanism 
by which activated GPR30 mediates these 
effects. Therefore, we need to reconsider the 
Fig. 3 . Relative strengths of the nongenomic inhibiting effects of ZEN analogs on bovine gonadotroph LH secretion (white font in black boxes) [42] and 
genomic effects of the ZEN analogs measured by the MCF7 human breast cell proliferation assay (black font in white boxes) [45]. White and black 
arrows indicate mycoestrogens synthesized by the Fusarium fungi and their metabolic pathways according to Erasmuson et al. [44], respectively.
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roles of endogenous estrogens and xenoes-
trogens in different cells in the reproduction 
process of various species.
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